Juan Ren Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2021	Downregulation of GPR4 and TCF7 Promotes Apoptosis and Inhibits Growth and Invasion of Ovarian Cancer Cells.
1/2021	Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
1/2020	Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
5/2011	Effects of ovarian cancer G protein coupled receptor 1 on the proliferation, migration, and adhesion of human ovarian cancer cells.
10/2010	[Effect of inhibitors of phospholipase A(2); on the metastasis potentials of human ovarian cancer cells].
9/2010	Tumor markers for early detection of ovarian cancer.
3/2006	Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Ren Research Topics

Disease

33	Neoplasms (Cancer) 01/2024 - 03/2010
7	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 03/2006
5	Infections 12/2019 - 11/2018
4	Colonic Neoplasms (Colon Cancer) 05/2023 - 09/2009
4	Colorectal Neoplasms (Colorectal Cancer) 05/2023 - 01/2017
4	Esophageal Squamous Cell Carcinoma 01/2023 - 02/2015
4	Hypoxia (Hypoxemia) 01/2022 - 04/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 03/2012
4	Carcinoma (Carcinomatosis) 01/2018 - 08/2002
3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2018
3	COVID-19 10/2023 - 01/2020
3	Inflammation (Inflammations) 01/2023 - 04/2022
3	Hyperglycemia 01/2023 - 06/2009
3	Multiple Myeloma 12/2021 - 09/2009
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2010
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2015
3	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 08/2009
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2011 - 02/2011
2	Disease Progression 04/2024 - 04/2024
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 04/2024
2	Dementia (Dementias) 01/2024 - 01/2021
2	Hemophilia A (Haemophilia) 11/2023 - 01/2022
2	Aplastic Anemia (Anemia, Hypoplastic) 10/2023 - 01/2017
2	Adenocarcinoma 01/2023 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2019
2	Lymphoma (Lymphomas) 12/2021 - 01/2014
2	Fatty Liver 02/2020 - 12/2018
2	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 12/2017
2	Lung Neoplasms (Lung Cancer) 05/2019 - 03/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 09/2011
2	Endometrial Neoplasms (Endometrial Cancer) 01/2014 - 01/2014
1	Cognitive Dysfunction 01/2024
1	Liver Neoplasms (Liver Cancer) 01/2024
1	Adenocarcinoma of Lung 08/2023
1	Stomach Neoplasms (Stomach Cancer) 05/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2023
1	Hematologic Neoplasms (Hematological Malignancy) 04/2023
1	Pelvic Pain 03/2023
1	Memory Disorders (Memory Loss) 02/2023
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2023
1	POEMS Syndrome (Syndrome, POEMS) 01/2023
1	Plasmacytoma 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2017
7	Proteins (Proteins, Gene)FDA Link 02/2023 - 03/2006
6	Long Noncoding RNAIBA 04/2024 - 10/2019
6	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 06/2009
6	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2014
4	Circular RNAIBA 01/2023 - 12/2020
4	lysophosphatidic acidIBA 01/2015 - 03/2006
3	VaccinesIBA 10/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 08/2023 - 01/2019
3	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 12/2020
3	CytokinesIBA 06/2022 - 04/2011
3	Indicators and Reagents (Reagents)IBA 01/2022 - 07/2011
3	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 01/2015
3	Fatty Acids (Saturated Fatty Acids)IBA 02/2020 - 11/2018
3	Inosine Triphosphate (ITP)IBA 04/2011 - 02/2011
2	RNA (Ribonucleic Acid)IBA 04/2024 - 09/2019
2	Factor VIII (Coagulation Factor VIII)IBA 11/2023 - 01/2022
2	Therapeutic UsesIBA 06/2022 - 01/2022
2	CateninsIBA 01/2022 - 10/2019
2	Nucleic AcidsIBA 06/2021 - 01/2020
2	Vorinostat FDA Link 01/2021 - 01/2014
2	Competitive Endogenous RNAIBA 12/2020 - 06/2020
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2020 - 05/2011
2	AcidsIBA 02/2020 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 04/2015
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 06/2009
2	Oxygen (Dioxygen)IBA 12/2017 - 04/2015
2	CholesterolIBA 03/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2016 - 04/2015
2	Conditioned Culture MediaIBA 04/2015 - 03/2006
2	Lysophosphatidic Acid ReceptorsIBA 01/2015 - 03/2006
2	Histone Deacetylase InhibitorsIBA 01/2014 - 01/2014
1	apatinibIBA 01/2024
1	ginsenoside Rk1IBA 01/2024
1	Oleanolic AcidIBA 01/2024
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2023
1	ginsenoside Rk3IBA 11/2023
1	er-xian decoctionIBA 10/2023
1	dixanthogen (EXD)IBA 10/2023
1	AzoxymethaneIBA 05/2023
1	B7-H1 AntigenIBA 05/2023
1	Dextran SulfateIBA 05/2023
1	Presenilin-1IBA 02/2023
1	XanthineIBA 01/2023

Therapy/Procedure

12	Radiotherapy 04/2023 - 09/2011
8	Therapeutics 05/2023 - 07/2011
6	Drug Therapy (Chemotherapy) 05/2023 - 08/2009
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2023 - 01/2022
2	Hematopoietic Stem Cell Transplantation 07/2022 - 12/2021
2	Neoadjuvant Therapy 01/2016 - 02/2015
2	Chemoradiotherapy 02/2015 - 03/2012
1	Pain Management 03/2023
1	Episiotomy 03/2023
1	Prostatectomy (Retropubic Prostatectomy) 03/2023
1	Treatment Delay 01/2023